// company-profile

Larimar Therapeutics, Inc.

LRMR
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings48Insiders19
// api This Larimar Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Larimar Therapeutics, Inc. insiders bought $0 across 6 transactions with no open-market sales.

  • Most active insider: THOMAS FRANK E with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Larimar Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$392.2M
QoQ change
+49.3%
Reporting period
2026-03-31
#1
DEERFIELD MANAGEMENT COMPANY, L.P.
CIK 1009258
$160.2M
35.6M shares
#2
Blue Owl Capital Holdings LP
CIK 1858703
$32.0M
7.1M shares
#3
MILLENNIUM MANAGEMENT LLC
CIK 1273087
$16.3M
3.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 19, 2026THOMAS FRANK ELRMR
Award
55,150$0.00$0K
May 19, 2026Truitt JosephLRMR
Award
55,150$0.00$0K
May 19, 2026SHERMAN JEFFREY WLRMR
Award
55,150$0.00$0K
May 19, 2026Flynn James ELRMR
Award
55,150$0.00$0K
May 19, 2026Hamilton Thomas EdwardLRMR
Award
55,150$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.